CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Analyst Reco. Charles River Laboratories International, Inc. Xetra

Equities

RV6

US1598641074

Delayed Xetra Other stock markets 16:35:34 10/08/2022 BST			5-day change	1st Jan Change
215.8 ^EUR	-2.40%		-.--%	-.--%

06-13	Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270	MT
06-07	The job report just threw a spanner in the works

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270	06-13	MT
Mizuho Initiates Charles River Laboratories International With Neutral Rating, $235 Price Target	06-07	MT
ANALYST RECOMMENDATIONS : Lyft, Amazon, Fedex, Xpo, Unilever...	06-07
ANALYST RECOMMENDATIONS : American Airlines, Salesforce, Five Below, Tesla, Okta...	06-06
TD Cowen Adjusts Price Target on Charles River Laboratories International to $228 From $260	05-13	MT
JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280	05-10	MT
Jefferies Adjusts Price Target on Charles River Laboratories International to $226 From $235	05-10	MT
Evercore ISI Adjusts Price Target on Charles River Laboratories International to $265 From $300	05-10	MT
Baird Adjusts Price Target on Charles River Laboratories International to $270 From $282	05-10	MT
Zacks Investment Research Adjusts Charles River Laboratories International's Price Target to $259 From $278	04-12	MT
Charles River Laboratories Signs Plasmid DNA Manufacturing Deal With Ship of Theseus	04-04	MT
Deutsche Bank Raises Price Target on Charles River Laboratories to $300 From $275, Keeps Buy Rating	03-22	MT
Argus Raises Price Target on Charles River Laboratories International to $290 From $200, Maintains Buy Rating	03-18	MT
Deutsche Bank Raises Charles River Laboratories International Price Target to $275 From $245, Maintains Buy Rating	02-16	MT
Morgan Stanley Raises Price Target on Charles River Laboratories International to $235 From $205, Keeps Equalweight Rating	02-16	MT
TD Cowen Adjusts Charles River Laboratories International's PT to $260 From $193, Keeps Market Perform Rating	02-15	MT
Stephens Adjusts Charles River Laboratories International's PT to $280 From $270, Keeps Overweight Rating	02-15	MT
Citigroup Adjusts Price Target on Charles River Laboratories International to $250 From $215, Maintains Neutral Rating	02-15	MT
UBS Adjusts Charles River Laboratories International Price Target to $290 From $270, Maintains Buy Rating	02-15	MT
JPMorgan Adjusts Price Target on Charles River Laboratories International to $280 From $270, Maintains Overweight Rating	02-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Charles River Laboratories International, Inc. Xetra

Equities

RV6

US1598641074

Analyst Reco.

Filters